Cleerly Is the Mammogram of the Heart with Jim Hartman
About this episode
Jim Hartman discusses the advancements in heart disease diagnosis through AI-driven technology and the commercial strategies behind Cleerly's growth.
In this episode, your host, Jordan Burgin, is joined by Jim Hartman, Chief Commercial Officer at Cleerly, to talk about why heart disease is still caught too late and how AI-driven coronary CT analysis is moving diagnosis upstream, before the heart attack ever happens. Jim shares the personal story behind his switch from cardiac surgery to prevention, breaks down what Cleerly actually sees inside the arteries, and walks through the commercial playbook he used to take the company from pre-revenue to scale from reimbursement battles to hiring for skill, will, and fit. Key Topics Why heart disease is still diagnosed “on the back end” and the case for imaging the heart What a Cleerly coronary CT analysis sees that a calcium score misses Building a commercial engine from pre-revenue to scale Hiring for skill, will, and fit in a mission-driven startup Related Insights The shift from a “sick-based” system to value-based, subscription-style care Why financial ROI now outweighs clinical enthusiasm in hospital sales Using AI tools for market segmentation and smarter territory planning Core Challenges Physician inertia: even with cutting-edge technology and a deep body of clinical data…
More episodes of The Crux of Medtech
- The First Commercial Hire Makes or Breaks Your Startup with Brandon Allen
- Nobody Cares About Better, Cheaper, Faster with Jim Surek
- The Doctor Who Put a Heart Attack Detector in Your Pocket with Dr. Dave Albert
- Putting an Expert Respiratory Therapist in Every Home with Anat Shani
Explore listener stats, chart rankings, contacts and more on the The Crux of Medtech podcast page.